Therefore, we predicted that inhibition of the β2-AR with propranolol may result in increased levels of p53, which is required for apoptosis in response to common chemotherapies as well as other drugs studied in preclinical NB models [31,32]. This evidence concerns the gene TP53 and neuroblastoma.